Why are some amyloidoses systemic? Does hepatic "chaperoning at a distance" prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis?

FASEB Journal

Volumn 26, Issue 6, 2012, Pages 2283-2293

  Buxbaum, Joel N ^a   Tagoe, Clement ^b   Gallo, Gloria ^c   Walker, John R ^d   Kurian, Sunil ^a   Salomon, Daniel R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Functional Genomics Institute of the Novartis Foundation   (United States)

Author keywords

Microarrays; Protein misfolding diseases

Indexed keywords

ANTIOXIDANT; CHAPERONE; HEAT SHOCK PROTEIN 110; HEAT SHOCK PROTEIN 40; PREALBUMIN; PROTEASOME; PROTEINASE; TRANSCRIPTION FACTOR; UBIQUITIN;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART; IMMUNE RESPONSE; LIVER; MITOCHONDRIAL GENE; MOUSE; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; PROTEIN FOLDING; STRESS; TRANSGENIC MOUSE;

AGING; AMYLOIDOSIS; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; LIVER; MALE; MICE; MICE, TRANSGENIC; MOLECULAR CHAPERONES; MYOCARDIUM; PREALBUMIN; UNFOLDED PROTEIN RESPONSE;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 84861772766     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-189571     Document Type: Article

References (37)

1. Sipe, J. D., Benson, M. D., Buxbaum, J. N., Ikeda, S., Merlini, G., Saraiva, M. J., and Westermark, P. (2010) Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 17, 101-104
2. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., and Stefani, M. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511 (Pubitemid 34288846)
3. Balch, W. E., Morimoto, R. I., Dillin, A., and Kelly, J. W. (2008) Adapting proteostasis for disease intervention. Science 319, 916-919 (Pubitemid 351263754)
4. Sekijima, Y., Wiseman, R. L., Matteson, J., Hammarstrom, P., Miller, S. R., Sawkar, A. R., Balch, W. E., and Kelly, J. W. (2005) The biological and chemical basis for tissue-selective amyloid disease. Cell 121, 73-85
5. Wiseman, R. L., Powers, E. T., Buxbaum, J. N., Kelly, J. W., and Balch, W. E. (2007) An adaptable standard for protein export from the endoplasmic reticulum. Cell 131, 809-821 (Pubitemid 350087203)
6. Buxbaum, J. N. (2007) Transthyretin and the transthyretin amyloidoses. In Protein Misfolding, Aggregation, and Conformational Diseases (Uversky, V. N., and Fink, A., eds.) pp. 259-283, Springer, Santa Cruz, CA, USA
7. Araki, S., and Yi, S. (2000) Pathology of familial amyloidotic polyneuropathy with TTR met 30 in Kumamoto, Japan. Neuropathology 20(Suppl.), S47-S51
8. Hofer, P. A., and Anderson, R. (1975) Postmortem findings in primary familial amyloidosis with polyneuropathy. Acta Pathol. Microbiol. Scand. A 83, 309-322
9. Teng, M. H., Yin, J. Y., Vidal, R., Ghiso, J., Kumar, A., Rabenou, R., Shah, A., Jacobson, D. R., Tagoe, C., Gallo, G., and Buxbaum, J. (2001) Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis. Lab. Invest. 81, 385-396 (Pubitemid 32245070)
10. Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., Cooke, M. P., Walker, J. R., and Hogenesch, J. B. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. U. S. A. 101, 6062-6067 (Pubitemid 38520528)
11. Horvath, S., Zhang, B., Carlson, M., Lu, K. V., Zhu, S., Felciano, R. M., Laurance, M. F., Zhao, W., Qi, S., Chen, Z., Lee, Y., Scheck, A. C., Liau, L. M., Wu, H., Geschwind, D. H., Febbo, P. G., Kornblum, H. I., Cloughesy, T. F., Nelson, S. F., and Mischel, P. S. (2006) Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc. Natl. Acad. Sci. U. S. A. 103, 17402-17407 (Pubitemid 44788981)
12. Zhang, B., and Horvath, S. (2005) A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 4, Article 17
13. Zhang, K., and Kaufman, R. J. (2006) Protein folding in the endoplasmic reticulum and the unfolded protein response. Handb. Exp. Pharmacol. 69-91
14. Van Anken, E., and Braakman, I. (2005) Endoplasmic reticulum stress and the making of a professional secretory cell. Crit. Rev. Biochem. Molec. Biol. 40, 269-283 (Pubitemid 43142394)
15. Powers, E. T., Morimoto, R. I., Dillin, A., Kelly, J. W., and Balch, W. E. (2009) Biological and chemical approaches to diseases of proteostasis deficiency. Annu. Rev. Biochem. 78, 959-991
16. Yi, S., Takahashi, K., Naito, M., Tashiro, F., Wakasugi, S., Maeda, S., Shimada, K., Yamamura, K., and Araki, S. (1991) Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene: Pathologic similarity to human familial amyloidotic polyneuropathy, type I. Am. J. Pathol. 138, 403-412
17. Santos, S. D., Fernandes, R., and Saraiva, M. J. (2010) The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems. Neurobiol. Aging 31, 280-289
18. Reixach, N., Foss, T. R., Santelli, E., Pascual, J., Kelly, J. W., and Buxbaum, J. N. (2008) Human-murine transthyretin heterotetramers are kinetically stable and non-amyloidogenic. A lesson in the generation of transgenic models of diseases involving oligomeric proteins. J. Biol. Chem. 283, 2098-2107
19. Hollien, J., Lin, J. H., Li, H., Stevens, N., Walter, P., and Weissman, J. S. (2009) Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J. Cell Biol. 186, 323-331
20. Sato, T., Susuki, S., Suico, M. A., Miyata, M., Ando, Y., Mizuguchi, M., Takeuchi, M., Dobashi, M., Shuto, T., and Kai, H. (2007) Endoplasmic reticulum quality control regulates the fate of transthyretin variants in the cell. EMBO J. 26, 2501-2512 (Pubitemid 46788312)
21. Ord, D., Meerits, K., and Ord, T. (2007) TRB3 protects cells against the growth inhibitory and cytotoxic effect of ATF4. Exp. Cell Res. 313, 3556-3567 (Pubitemid 47404553)
22. Jousse, C., Deval, C., Maurin, A. C., Parry, L., Cherasse, Y., Chaveroux, C., Lefloch, R., Lenormand, P., Bruhat, A., and Fafournoux, P. (2007) TRB3 inhibits the transcriptional activation of stress-regulated genes by a negative feedback on the ATF4 pathway. J. Biol. Chem. 282, 15851-15861 (Pubitemid 47093266)
23. Ohoka, N. (2005) TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J. 24, 1243-1255
24. Hegedus, Z. (2007) Tribbles: a family of kinase-like proteins with potent signalling regulatory function. Cell. Signal. 19, 238-250
25. Jung, K. A., and Kwak, M. K. (2010) The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 15, 7266-7291
26. Teixeira, P. F., Cerca, F., Santos, S. D., and Saraiva, M. J. (2006) Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy. J. Biol. Chem. 281, 21998-22003 (Pubitemid 44181903)
27. Yoshida, H., Oku, M., Suzuki, M., and Mori, K. (2006) pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response. J. Cell Biol. 172, 565-575 (Pubitemid 43243877)
28. Yoshida, H., Uemura, A., and Mori, K. (2009) pXBP1(U), a negative regulator of the unfolded protein response activator pXBP1(S), targets ATF6 but not ATF4 in proteasome-mediated degradation. Cell Struct. Funct. 34, 1-10
29. Fernandez-Marcos, P. J., and Auwerx, J. (2011) Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am. J. Clin. Nutr. 93, 884S-890S
30. Madrazo, J. A., and Kelly, D. P. (2008) The PPAR trio: regulators of myocardial energy metabolism in health and disease. J. Mol. Cell. Cardiol. 44, 968-975
31. Shoag, J., and Arany, Z. (2010) Regulation of hypoxia-inducible genes by PGC-1 alpha. Arterioscler. Thromb. Vasc. Biol. 30, 662-666
32. Santos, S. D., Magalhaes, J., and Saraiva, M. J. (2008) Activation of the heat shock response in familial amyloidotic polyneuropathy. J. Neuropathol. Exp. Neurol. 67, 449-455 (Pubitemid 351653536)
33. Sousa, M. M., do Amaral, J. B., Guimaraes, A., and Saraiva, M. J. (2005) Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin, and matrix metalloproteinase-9 in familial amyloid polyneuropathy. FASEB J. 19, 124-126 (Pubitemid 40069939)
34. Stangou, A. J., Heaton, N. D., and Hawkins, P. N. (2005) Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation. N. Engl. J. Med. 352, 2356 (Pubitemid 40740565)
35. Takei, Y., Gono, T., Yazaki, M., Ikeda, S., Ikegami, T., Hashikura, Y., Miyagawa, S., and Hoshii, Y. (2007) Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver. Liver Transpl. 13, 215-218 (Pubitemid 46351646)
36. Yamamoto, S., Wilczek, H. E., Iwata, T., Larsson, M., Gjertsen, H., Soderdahl, G., Solders, G., and Ericzon, B. G. (2007) Long-term consequences of domino liver transplantation using familial amyloidotic polyneuropathy grafts. Transpl. Int. 20, 926-933 (Pubitemid 47537564)
37. Llado, L., Baliellas, C., Casasanovas, C., Ferrer, I., Fabregat, J., Ramos, E., Castellote, J., Torras, J., Xiol, X., and Rafecas, A. (2010) Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation. Liver Transpl. 16, 1386-1392